GNRH1 and ovarian hyperstimulation syndrome: It is currently standard practice to use a GnRH agonist trigger and a ‘freeze-all’ strategy as a preventive measure for high-responders at risk of OHSS; however, the BEYOND trial did not permit this as it would have confounded the primary outcome results, as discussed above.